Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Eli Lilly (NYSE: LLY) has been a growth beast over the years and is now easily the most valuable healthcare company in the ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. [Photo/Agencies] United States-based pharmaceutical company Eli Lilly will continue to pour ...

The stock's rise snapped a five-day losing streak.

Eli Lilly will acquire privately held SiteOne Therapeutics, the companies said on Tuesday, giving the drugmaker access to an ...

Migraine is recognized globally as the seventh most disabling condition across all diseases, accounting for approximately 2.9% of all years lived with disability (YLDs). It is also the top cause of ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

It’s not surprising that giants such as Novartis and Eli Lilly have promised Trump they’ll invest billions ... Brandon Daniels, CEO of supply chain company Exiger, is bullish on tariffs. He thinks ...

NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S. drugs regulator clamps down on mass production of ...